CD36 and cancer: Cancer cells take advantage of two main fatty acid sources: de novo fatty acid synthesis, which is increased in several cancer cells including liver, prostate, colon and breast cancers [3], and the uptake from the surrounding extracellular microenvironment through transport proteins such as CD36 or Fatty Acid Binding Proteins (FAPBs) [4].